autophagi
process
lysosom
degrad
origin
describ
cellular
respons
adapt
lack
nutrient
enabl
elimin
damag
organel
autophagi
increasingli
recogn
process
also
involv
innat
adapt
immun
respons
pathogen
studi
regul
autophagi
uncov
compon
autophag
cascad
manipul
pharmacolog
approach
modul
autophagi
may
result
novel
strategi
treatment
prevent
variou
infect
degrad
macromolecul
essenti
aspect
cellular
homeostasi
two
major
pathway
catabol
macromolecul
one
depend
proteasom
structur
respons
select
degrad
shortliv
protein
second
pathway
known
macroautophagi
lead
lysosom
degrad
variou
macromolecul
includ
longliv
protein
organel
macroautophagi
usual
refer
autophagi
process
conserv
eukaryot
wherebi
portion
cytosol
whole
organel
encircl
isol
membran
expans
membran
result
complet
engulf
cytosolorganel
within
doublemembran
vesicl
call
autophagosom
structur
fuse
late
endosom
lysosom
result
lysosom
degrad
content
autophagi
homeostat
mechan
present
basal
level
almost
cell
autophagi
enhanc
variou
condit
cellular
stress
nutrient
depriv
accumul
damag
organel
breakdown
content
autophagosom
provid
substrat
necessari
cell
surviv
period
starvat
also
serv
purpos
elimin
damag
organel
role
autophagi
extend
beyond
catabol
process
enabl
cell
surviv
starvat
organel
turnov
autophagi
known
result
cell
death
apoptosi
inhibit
addit
autophagi
import
develop
age
protect
cancer
variou
neurodegen
liver
muscl
diseas
also
increas
evid
link
autophagi
mechan
resist
pathogen
fact
autophagi
involv
pathogenesi
numer
diseas
made
cellular
respons
attract
therapeut
target
effect
manipul
autophagi
requir
understand
molecular
event
govern
process
pathway
control
autophagi
complex
subject
recent
review
summar
salient
aspect
molecular
pathway
involv
autophagi
serinethreonin
kinas
mammalian
target
rapamycin
mtor
key
regul
autophagi
figur
inhibit
mtor
stimul
autophagi
enhanc
mtor
activ
impair
autophagi
inhibit
mtor
result
enhanc
autophagi
typic
accomplish
experiment
treat
cell
rapamycin
downstream
mtor
lie
group
autophagyrel
protein
atg
atg
highli
conserv
yeast
human
yeast
kinas
lie
downstream
target
rapamycin
regul
format
autophagosom
role
autophagi
mammalian
homolog
well
understood
anoth
central
regul
autophagi
studi
perform
yeast
reveal
essenti
format
isol
membran
promot
recruit
atg
structur
mammalian
homolog
usual
refer
beclin
figur
beclin
form
complex
protein
notabl
class
iii
phosphoinositol
kinas
also
known
beclin
promot
autophagi
process
requir
interact
beclin
abil
beclin
associ
regul
compon
multiprotein
complex
ultraviolet
radiat
resistanceassoci
gene
activ
molecul
beclin
autophagi
ambra
bind
beclin
increas
interact
beclin
thu
stimul
autophagi
contrast
bind
antiapoptot
protein
beclin
impair
interact
beclin
result
inhibit
autophagi
elong
isol
membran
depend
recruit
atg
protein
protein
act
two
ubiquitinlik
conjug
system
cascad
figur
coval
conjug
conjug
associ
form
approxim
protein
complex
target
isol
membran
process
promot
conjug
lipid
phosphatidylethanolamid
pe
process
transform
cytosol
autophagosom
membranebound
peconjug
ii
pattern
express
punctat
oppos
diffus
level
express
ii
classic
marker
autophagi
autophagosom
form
complet
wrap
intracellular
content
isol
membran
follow
interact
autophagosom
late
endosomeslysosom
process
govern
gtpase
final
activ
hydrolyt
enzym
present
autolysosom
degrad
cargo
mtor
beclin
import
regul
autophagi
evid
process
occur
independ
molecul
exampl
mtorindepend
autophagi
uncov
studi
inositol
deriv
free
inositol
ip
endogen
inhibitor
autophagi
figur
lithium
inhibit
inositol
monophosphatas
caus
reduct
free
inositol
ip
level
result
promot
autophagi
independ
mtor
addit
noncanon
beclin
autophagi
occur
breast
cancer
cell
treat
resveratrol
reactiv
oxygen
speci
stimul
autophagi
manner
partial
independ
beclin
mani
intracellular
cascad
report
affect
autophagi
cascad
relev
respons
infecti
organ
consist
interferoninduc
dsrnadepend
protein
kinas
r
pkr
downstream
molecul
eukaryot
initi
factor
molecul
import
compon
innat
respons
virus
impair
viral
protein
synthesi
viral
replic
pkr
also
report
promot
starvationand
viralinduc
autophagi
one
area
great
interest
deciph
role
autophagi
mechan
resist
pathogen
studi
use
variou
bacteria
provid
clear
evid
autophagi
act
mechan
pathogen
clearanc
mycobacterium
tuberculosi
prevent
phagolysosom
fusion
strategi
persist
within
macrophag
stimul
autophagi
starvat
rapamycin
result
coloc
autophagi
protein
mycobacteri
phagosom
phagolysosom
fusion
kill
tuberculosi
streptococcu
pyogen
invad
cytosol
epitheli
cell
target
autophagosomelik
compart
lead
lysosom
degrad
bacteria
studi
cell
reveal
autophag
pathway
caus
transient
bacteri
clearanc
similar
pyogen
staphylococcu
aureu
subject
autophag
elimin
interestingli
strain
methicillinresist
aureu
escap
autophagosom
shigella
flexneri
normal
avoid
autophagi
within
epitheli
cell
bacteri
protein
virg
normal
bind
induc
autophagi
howev
autophagi
prevent
wildtyp
bacteria
secret
virul
factor
icsb
prevent
recognit
virg
thu
flexneri
express
icsb
becom
suscept
kill
via
autophagi
autophagi
report
mediat
kill
bacteria
infect
listeria
monocytogen
induc
autophagi
nonmotil
acta
mutant
l
monocytogen
treat
chloramphenicol
target
autophagosom
cytosol
infect
cell
studi
use
mous
embryon
fibroblast
mef
reveal
autophagi
limit
bacteri
growth
earli
stage
infect
bacteria
begin
multipli
cytosol
autophagi
modul
bacteri
product
express
lysteriolysin
llo
requir
induct
autophagi
infect
cell
probabl
llo
would
allow
bacteri
escap
vacuol
cytosol
lead
initi
induct
autophagi
subsequ
express
bacteri
phospholipas
c
acta
would
promot
bacteri
growth
inhibit
autophagi
autophagi
also
limit
growth
salmonella
typhimurium
typhimurium
escap
salmonellacontain
vacuol
resid
cytosol
target
autophagosom
similar
studi
l
monocytogen
work
use
cell
reveal
autophagi
limit
bacteri
growth
autophagi
also
regul
intracellular
surviv
burkholderia
pseudomallei
fraction
bacteria
coloc
autophagosom
marker
bopa
bacteri
type
iii
secret
protein
inhibit
autophagi
howev
pharmacolog
stimul
autophagi
result
decreas
bacteri
surviv
autophagi
may
benefici
lead
bacteri
degrad
also
protect
cell
effect
bacteri
toxin
inde
autophagi
protect
cell
effect
vibrio
cholera
cytolysin
contrast
previou
studi
autophagi
may
promot
growth
certain
bacteria
case
legionella
pneumophila
propos
rapid
induct
autophagi
may
lead
control
pathogen
patternrecognit
receptor
prr
modul
autophagi
may
promot
pathogen
clearanc
tolllik
receptor
tlr
ligand
lipopolysaccharid
lp
induc
autophagi
process
requir
adaptor
receptor
domaincontain
adaptorinduc
trif
effect
appear
function
relev
sinc
lpsinduc
autophagi
enhanc
coloc
tuberculosi
autophagosom
howev
contrast
studi
anoth
group
fail
detect
stimul
autophagi
primari
macrophag
treat
lp
tlr
signal
link
autophagi
phagocytosi
signal
time
phagocytosi
induc
recruit
phagosom
although
convent
autophagosom
detect
associ
rapid
profound
acidif
phagosom
similar
previou
studi
appear
tlr
enhanc
kill
pathogen
stimul
autophagi
molecul
sinc
degrad
yeast
saccharomyc
cerevisia
inhibit
knockdown
autophagi
gene
subsequ
studi
reveal
induc
autophagi
moreov
stimul
autophagi
via
promot
elimin
tuberculosi
variant
bovi
bacil
bcg
manner
discuss
prr
induc
autophagi
mediat
vivo
resist
l
monocytogen
drosophila
recent
studi
identifi
molecular
link
tlr
autophagi
tlr
signal
increas
interact
trif
adaptor
protein
downstream
tlr
beclin
trif
diminish
bind
beclin
inhibitor
autophagi
autophagi
involv
innat
respons
bacteria
directli
antimicrobi
autophagosom
coloc
intracytoplasm
francisella
tularensi
although
autophagi
report
mediat
antimicrobi
activ
potenti
relev
immun
respons
f
tularensi
mhc
class
ii
detect
autophagosom
contain
bacteria
macrophag
especi
lack
exhibit
autophagosom
format
associ
flexneri
autophagi
mediat
antibacteri
activ
autophagi
appear
protect
macrophag
shigellainduc
cell
death
initi
evid
role
autophagi
innat
immun
pathogen
came
studi
virus
neuron
overexpress
beclin
protect
mice
lethal
sindbi
viru
enceph
pkrand
autophagi
mediat
degrad
herp
simplex
viru
type
viru
produc
neurovirul
factor
inhibit
autophagi
revers
pkrmediat
phosphoryl
antagon
beclin
studi
import
also
provid
strong
evid
vivo
role
autophagi
host
protect
mutant
encod
protein
unabl
bind
beclin
becom
neuroattenu
mice
neurovirul
mutant
restor
pkrdefici
mice
recent
studi
drosophila
provid
support
notion
autophagi
mediat
vivo
protect
l
monocytogen
vesicular
stomat
viru
vsv
recognit
diaminopimel
acidtyp
peptidoglycan
prr
peptidoglycan
recognit
protein
pgrp
le
crucial
induct
autophagi
l
monocytogen
infect
express
mutant
pgrple
knockdown
pgrple
caus
increas
lethal
infect
fli
vsv
infect
induc
autophagi
drosophila
cell
fli
autophagi
appear
trigger
recognit
vsv
glycoprotein
g
importantli
autophagi
mediat
host
protect
sinc
autophagi
defici
fli
suscept
vsv
product
type
interferon
plasmacytoid
dendrit
cell
anoth
aspect
innat
immun
viru
control
autophagi
protein
case
sendai
viru
vsv
requir
deliveri
ssrna
present
endosom
compart
result
strong
type
interferon
innat
respons
virus
contrast
anoth
studi
report
autophagi
protein
neg
regul
type
interferon
product
infect
vsv
conjug
inhibit
type
interferon
product
associ
retino
acidinduc
gene
rigi
promot
stimul
caspas
recruit
domain
inhibit
type
interferon
product
would
promot
viral
replic
import
question
whether
autophagi
function
innat
mechan
resist
pathogen
whether
activ
adapt
immun
studi
tuberculosi
indic
might
case
known
stimul
autophagi
cytokin
caus
fusion
phagosom
contain
tuberculosi
late
endosomeslysosom
autophagi
kill
bcg
depend
immunityrel
gtpase
effect
autophagi
inhibit
cytokin
base
find
propos
induc
antimycobacteri
activ
autophagi
studi
use
toxoplasma
gondii
provid
proof
autophagi
activ
adapt
immun
induc
pathogen
kill
gondii
oblig
intracellular
protozoan
surviv
within
host
cell
resid
parasitophor
vacuol
avoid
fusion
lysosom
member
tnf
receptor
superfamili
express
antigen
present
cell
includ
macrophag
rerout
parasitophor
vacuol
lysosom
compart
via
autophagi
caus
kill
parasit
stimul
macrophag
result
coloc
around
parasitophor
vacuol
follow
fusion
late
endosomeslysosom
multipl
genet
pharmacolog
approach
impair
autophagi
lysosom
degrad
demonstr
autophagi
respons
kill
gondii
autophag
kill
gondii
requir
synergi
adaptor
protein
downstream
independ
irg
protein
irgd
like
autophagi
mediat
least
part
vivo
protect
effect
gondii
human
mice
macrophag
exhibit
autophagosom
format
around
gondii
howev
format
autophagosom
macrophag
probabl
caus
death
parasit
rather
respons
presenc
alter
structur
disrupt
parasitophor
membran
denud
tachyzoit
within
host
cell
inde
genet
pharmacolog
inhibit
autophagi
lysosom
degrad
affect
antit
gondii
activ
induc
ablat
caus
recent
studi
report
import
immuneactiv
autophagi
control
chlamydia
trachomati
mef
treat
exhibit
enhanc
interact
c
trachomati
inclus
late
endosomeslysosom
irg
protein
necessari
fusion
autophagosom
rerout
lysosom
present
microbi
antigen
cell
anoth
aspect
adapt
immun
appear
enhanc
autophagi
mhc
class
iiposit
cell
includ
dendrit
b
epitheli
cell
exhibit
constitut
autophagosom
format
autophagosom
continu
fuse
multivesicular
mhc
class
iiload
compart
appear
role
autophagi
antigen
present
may
antigen
specif
autophagi
found
involv
antigen
recognit
epsteinbarr
viru
ebv
nuclear
antigen
tcell
clone
contrast
report
present
mhc
class
ii
molecul
ebvtransform
bcell
line
autophagi
result
may
relev
sinc
cell
recogn
ebna
inhibit
growth
ebvtransform
lymphoblastoid
cell
line
autophagi
may
promot
host
protect
improv
recognit
microbi
antigen
inde
model
immun
tuberculosisinfect
dendrit
cell
pretreat
cell
rapamycin
induc
autophagi
improv
vivo
protect
challeng
tuberculosi
recent
studi
uncov
role
autophagi
present
microbi
antigen
cell
macrophag
infect
present
viral
antigen
glycoprotein
b
involv
initi
classic
mhc
class
pathway
follow
autophagi
facilit
process
glycoprotein
b
activ
cell
autophagi
antigen
present
enhanc
immun
mice
influenzainfect
fibroblast
undergo
autophagi
prior
cell
death
result
enhanc
prime
hemagglutininspecif
cell
enhanc
prime
probabl
mediat
prolong
mhc
crosspresent
product
type
interferon
dendrit
cell
phagocytos
die
fibroblast
studi
support
stimul
autophagi
may
improv
immun
strategi
variou
pathogen
increas
evid
indic
autophagi
protein
regul
cellular
respons
autophagi
autophagi
mediat
antit
gondii
activ
trigger
involv
autophagyindepend
kill
parasit
phagocyt
cell
requir
recruit
irg
protein
parasitophor
vacuol
damag
structur
clearanc
parasit
futur
attempt
stimul
autophagi
therapeut
approach
infect
consid
possibl
approach
may
univers
benefici
exampl
suggest
rna
virus
polioviru
mous
hepat
viru
use
autophagosom
membran
scaffold
promot
viral
genom
replic
note
recent
studi
primari
macrophag
find
role
autophagi
replic
mous
hepat
viru
autophagi
also
enhanc
replic
coxsackieviru
addit
state
conjug
appear
promot
vitro
replic
vsv
mef
impair
type
interferon
product
role
autophagi
pathogenesi
mani
disord
elimin
certain
pathogen
spark
interest
manipul
autophagi
therapeut
purpos
address
pathogen
may
amen
therapeut
manipul
autophagi
caveat
design
approach
summar
work
examin
effect
stimul
autophagi
mani
import
studi
explor
therapeut
manipul
autophagi
conduct
model
infect
rather
model
neurodegener
includ
studi
sinc
conserv
natur
mani
featur
autophagi
suggest
result
studi
may
applic
futur
attempt
manipul
autophagi
enhanc
protect
pathogen
studi
model
neurodegen
diseas
support
concept
target
mtor
activ
enhanc
autophagi
therapeut
benefit
accumul
aggreg
protein
import
featur
neurodegen
disord
enhanc
degrad
protein
propos
potenti
therapeut
approach
diseas
rapamycin
inhibit
mtor
thu
stimul
autophagi
figur
rapamycin
report
enhanc
clearanc
aggregatepron
protein
within
cell
diminish
toxic
accumul
neuron
hallmark
parkinson
diseas
cell
treat
rapamycin
exhibit
increas
clearanc
rapamycin
also
exhibit
protect
effect
vivo
express
aggregatepron
mutant
protein
result
toxic
abnorm
eye
decreas
surviv
drosophila
vivo
administr
rapamycin
diminish
toxic
improv
surviv
promot
clearanc
aggregatepron
protein
protect
effect
rapamycin
probabl
mediat
autophagi
sinc
drug
fail
induc
protect
drosophila
defici
autophagi
protein
moreov
rapamycin
analog
decreas
aggreg
format
improv
perform
behavior
task
mous
model
huntington
diseas
vitro
studi
use
tuberculosi
gondii
b
pseudomallei
also
suggest
pharmacolog
stimul
autophagi
may
improv
control
pathogen
treatment
macrophag
rapamycin
induc
coloc
autophagosom
marker
around
gondiicontain
parasitophor
vacuol
enhanc
acidif
mycobacteri
phagosom
accompani
antimicrobi
activ
effect
rapamycin
unlik
mediat
direct
antimicrobi
activ
rapamycin
macrolid
sinc
knockdown
beclin
remark
impair
antit
gondii
activ
induc
rapamycin
rapamycin
also
result
decreas
surviv
b
pseudomallei
studi
provid
impetu
explor
autophagi
stimul
enhanc
pathogen
erad
kept
mind
immunosuppress
activ
rapamycin
rais
concern
regard
efficaci
approach
base
sole
administr
drug
anoth
studi
report
small
molecul
enhanc
rapamycin
identifi
screen
yeast
caus
kill
bcg
within
macrophag
identif
mtorindepend
autophagi
uncov
potenti
therapeut
target
stimul
autophagi
lithium
diminish
ip
level
thu
stimul
autophagi
figur
lithium
report
promot
clearanc
mutant
huntingtin
howev
proautophagi
activ
lithium
partial
antagon
addit
effect
drug
autophagi
signal
lithium
also
inhibit
glycogen
synthas
result
mtor
activ
activ
mtor
impair
autophagi
result
may
therapeut
relev
combin
lithium
plu
rapamycin
exhibit
greater
protect
neurodegener
fli
model
huntington
diseas
drug
individu
pharmacolog
inhibit
ip
receptor
use
xestospongin
b
also
report
stimul
autophagi
figur
recent
studi
identifi
ca
channel
antagonist
minoxidil
clonidin
mtorindepend
stimul
autophagi
drug
show
benefici
effect
model
huntington
diseas
drosophila
zebrafish
beclin
may
anoth
therapeut
target
modul
autophagi
level
beclin
appear
import
factor
control
autophagi
regard
overexpress
beclin
protect
mice
lethal
sindbi
viru
enceph
exampl
beclin
defici
promot
neurodegener
mice
relev
tamoxifen
appear
stimul
autophagi
least
part
enhanc
express
beclin
figur
activ
beclin
also
target
pharmacolog
bclx
l
bind
domain
beclin
inhibit
autophagi
pharmacolog
mimet
stimul
autophagi
drug
competit
inhibit
interact
beclin
l
prevent
molecul
inhibit
autophagi
figur
mention
tlr
induc
autophagi
manipul
tlr
signal
propos
potenti
approach
promot
pathogen
control
inde
enhanc
coloc
tuberculosi
autophagosom
pathogen
elimin
autophagi
link
antigen
present
appear
direct
immunogen
autophag
pathway
may
improv
abil
vaccin
induc
helper
tcell
stimul
regard
fusion
influenza
matrix
protein
target
antigen
autophagosom
caus
fourto
increas
mhc
class
ii
present
cell
figur
evid
pathogen
util
autophagi
promot
growth
indic
stimul
autophagi
unlik
benefici
infect
exampl
rapamycin
enhanc
growth
pathogen
includ
polioviru
coxsackieviru
coxiella
burnetti
approach
stimul
autophagi
may
therapeut
valu
infect
caus
pathogen
suscept
autophag
kill
studi
explor
differ
arm
immun
respons
activ
autophagi
may
identifi
molecular
target
select
induc
autophag
elimin
pathogen
stimul
autophagi
may
also
benefici
pathogen
avoid
autophagi
may
accomplish
prevent
virul
factor
block
autophagi
contrast
treatment
pathogen
util
autophagi
promot
growth
may
accomplish
inhibit
autophagi
block
effect
factor
subvert
autophagi
summari
experiment
evid
suggest
stimul
autophagi
may
facilit
pathogen
erad
immun
recognit
howev
import
consid
caveat
approach
first
drug
use
far
stimul
autophagi
like
specif
alter
cellular
function
second
molecul
autophagi
signal
mtor
control
cellular
respons
addit
autophagi
third
gener
inhibit
autophagi
affect
cellular
homeostasi
exampl
autophagi
modul
tcell
homeostasi
autophagi
mediat
tcell
death
growth
factor
withdraw
moreov
cell
exhibit
higher
level
autophagi
cell
growth
factor
withdraw
thu
stimul
autophagi
may
result
preferenti
loss
cell
impair
humor
immun
fourth
certain
eukaryot
pathogen
may
express
autophagi
util
process
virul
mechan
caveat
could
address
target
key
regul
autophagi
identifi
studi
immunebas
activ
autophagi
pathogeninduc
evas
subvers
process
addit
new
specif
small
molecul
modul
autophagi
could
identifi
use
screen
yeast
recent
report
futur
studi
aim
character
regul
autophagi
identif
select
modul
process
may
prove
fruit
quest
improv
treatment
prevent
variou
infect
autophagi
initi
describ
homeostat
mechan
stimul
within
cell
respons
starvat
order
provid
cell
substrat
macromolecul
synthesi
atp
product
autophagi
recogn
play
adapt
role
mani
condit
includ
infect
consider
interest
develop
approach
treat
infect
base
manipul
autophagi
cascad
andor
pathway
regul
process
increas
evid
role
autophagi
antigen
present
suggest
modul
autophagi
may
repres
novel
approach
improv
immunogen
vaccin
design
approach
specif
modul
autophagi
therapeut
purpos
infect
probabl
requir
achiev
better
understand
regul
autophagi
particular
need
dissect
pathway
immun
respons
trigger
autophagi
identifi
counter
measur
use
organ
prevent
autophagi
subvert
process
promot
growth
given
highli
conserv
natur
autophag
pathway
yeast
mammal
identif
new
agent
select
modul
autophagi
facilit
use
screen
yeast
major
effort
current
devot
mani
scientist
studi
autophagi
rais
possibl
import
advanc
design
measur
treat
prevent
infect
may
becom
realiti
near
futur
autophagi
homeostat
intracellular
mechan
regul
variou
aspect
interact
host
pathogen
autophagi
stimul
differ
compon
immun
system
trigger
degrad
differ
pathogen
certain
microorgan
activ
block
autophagi
surviv
within
host
cell
pathogen
util
autophagi
machineri
promot
growth
autophagi
enhanc
antigen
present
thu
stimul
adapt
immun
autophagi
also
influenc
tcell
homeostasi
differenti
complex
role
autophagi
hostpathogen
interact
indic
manipul
cellular
respons
probabl
need
tailor
pathogen
interest
vitro
studi
shown
valid
pharmacolog
modul
autophagi
promot
pathogen
erad
vivo
studi
carri
primarili
model
neurodegener
demonstr
therapeut
benefit
modul
autophagi
pharmacolog
agent
current
avail
modul
autophagi
typic
exhibit
nonspecif
effect
design
ration
therapeut
approach
probabl
requir
better
understand
immun
system
trigger
autophagi
pathogen
block
subvert
process
strategi
util
enhanc
autophagi
includ
inhibit
mtor
rapamycin
analog
rapamycin
inhibit
ip
level
ip
r
upregul
beclin
inhibit
beclin
l
interact
antigen
fuse
target
autophagosom
result
enhanc
mhc
class
ii
present
mtor
mammalian
target
rapamycin
ip
inositol
triphosph
ip
r
inositol
triphosph
receptor
